-
1
Treatment of HCV infection in patients with steatotic liver disease
Published 2024-07-01Subjects: Get full text
Article -
2
Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
Published 2024-05-01Subjects: “…steatotic liver disease…”
Get full text
Article -
3
Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
Published 2024-12-01Subjects: Get full text
Article -
4
Effect of a Ketogenic Diet on Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) Progression: A Randomized Controlled Trial
Published 2025-01-01Subjects: “…metabolic dysfunction‐associated steatotic liver disease…”
Get full text
Article -
5
Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
Published 2025-01-01Subjects: “…metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
6
Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma
Published 2025-01-01Subjects: “…Metabolic Dysfunction-Associated Steatotic Liver Disease…”
Get full text
Article -
7
The clinical value of serum sirtuin-1 concentration in the diagnosis of metabolic dysfunction-associated steatotic liver disease
Published 2025-01-01Subjects: “…Metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
8
Serum dihomo-g-linolenic acid concentration as a potential novel noninvasive biomarker for liver steatosis detection in children
Published 2024-12-01Subjects: “…metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
9
Augmenter of Liver Regeneration Crotonylation Assists in Mitochondria-ER Contact to Alleviate Hepatic SteatosisSummary
Published 2025-01-01Subjects: “…Metabolic Dysfunction-associated Steatotic Liver Disease…”
Get full text
Article -
10
Associations between systemic inflammatory biomarkers and metabolic dysfunction associated steatotic liver disease: a cross-sectional study of NHANES 2017–2020
Published 2025-01-01Subjects: “…Metabolic dysfunction associated steatotic liver disease (MASLD)…”
Get full text
Article -
11
Establishing of a risk prediction model for metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study
Published 2025-01-01Subjects: “…Metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
12
Impact of shear wave elastography and attenuation imaging for predicting life-threatening event in patients with metabolic dysfunction-associated steatotic liver disease
Published 2025-02-01Subjects: “…Metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
13
Association of daily step counts and step intensity with mortality among US adults: a cross–sectional study of NHANES 2005–2006
Published 2025-01-01Subjects: “…Metabolic dysfunction–associated steatotic liver disease…”
Get full text
Article -
14
Development and validation of machine learning models for MASLD: based on multiple potential screening indicators
Published 2025-01-01Subjects: “…metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
15
Liver macrophage activation: Relation with hepatic histopathological changes in patients with metabolic associated steatotic liver disease
Published 2024-06-01Subjects: “…metabolic associated steatotic liver disease…”
Get full text
Article -
16
The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease
Published 2023-09-01Subjects: “…metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
17
From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease
Published 2025-01-01Subjects: “…Metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
18
The fibrosis-4 index and its association with carotid atherosclerosis in type 2 diabetes: a cross-sectional study in China
Published 2025-01-01Subjects: “…Metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
19
Identification of EGR1 as a Key Diagnostic Biomarker in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Through Machine Learning and Immune Analysis
Published 2025-02-01Subjects: “…metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
20
Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD
Published 2025-01-01Subjects: “…metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article